Nucleotide excision repair deficiency is intrinsic in sporadic stage i breast cancer

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 50, 2010, Pages 21725-21730

  Latimer, Jean J ^a,b   Johnson, Jennifer M ^b,c   Kelly, Crystal M ^a   Miles, Tiffany D ^b   Beaudry Rodgers, Kelly A ^d   Lalanne, Nancy A ^b   Vogel, Victor G ^b,c   Kanbour Shakir, Amal ^a   Kelley, Joseph L ^a   Johnson, Ronald R ^a   Grant, Stephen G ^b,d  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Breast epithelial attached epispher; Human breast tumor explant culture; Human primary breast cell explant culture; Hypermutability

Indexed keywords

CISPLATIN; GENE PRODUCT;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST EPITHELIUM; CANCER STAGING; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC DISORDER; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE EXCISION REPAIR DEFICIENCY; PRIORITY JOURNAL; UNSCHEDULED DNA SYNTHESIS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DNA DAMAGE; DNA REPAIR; FEMALE; HUMANS; MICROARRAY ANALYSIS; MIDDLE AGED; RNA, MESSENGER;

EID: 78650735877     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0914772107     Document Type: Article

References (58)

1. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57-70.
2. Loeb LA (1991) Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 51:3075-3079.
3. Ishikawa T, et al. (2001) Importance of DNA repair in carcinogenesis: Evidence from transgenic and gene targeting studies. Mutat Res 477:41-49.
4. Thompson LH (1998) Nucleotide excision repair: its relation to human disease. DNA Damage and Repair, Volume 2: DNA Repair in Higher Eukaryotes, eds Nickoloff JA, Hoekstra MF (Humana Press, Totowa, NJ), pp 335-393.
5. de Boer J, Hoeijmakers JHJ (2000) Nucleotide excision repair and human syndromes. Carcinogenesis 21:453-460.
6. Kraemer KH, Lee MM, Scotto J (1984) DNA repair protects against cutaneous and internal neoplasia: Evidence from xeroderma pigmentosum. Carcinogenesis 5:511-514.
7. Cleaver JE, Thomas GH (1981) Measurement of unscheduled synthesis by autoradiography. DNA Repair, A Laboratory Manual of Research Procedures, eds Friedberg EC, Hanawalt PC (Marcel Dekker, New York), Vol I, pp 277-287.
8. Goode EL, Ulrich CM, Potter JD (2002) Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 11:1513-1530.
9. Shen H, et al. (2001) An intronic poly (AT) polymorphism of the DNA repair gene XPC and risk of squamous cell carcinoma of the head and neck: A case-control study. Cancer Res 61:3321-3325.
10. Bedford P, et al. (1988) Differential repair of platinum-DNA adducts in human bladder and testicular tumor continuous cell lines. Cancer Res 48:3019-3024.
11. Köberle B, et al. (1997) DNA repair capacity and cisplatin sensitivity of human testis tumour cells. Int J Cancer 70:551-555.
12. Quintela-Fandino M, et al. (2006) DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy. J Clin Oncol 24:4333-4339.
13. Kalikaki A, et al. (2009) DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer. Clin Lung Cancer 10:118-123.
14. Chew HK, et al. (2009) Phase II studies of gemcitabine and cisplatin in heavily and minimally pretreated metastatic breast cancer. J Clin Oncol 27:2163-2169.
15. Kovacs E, Stucki D, Weber W, Müller HJ (1986) Impaired DNA-repair synthesis in lymphocytes of breast cancer patients. Eur J Cancer Clin Oncol 22:863-869.
16. Ramos JM, et al. (2004) DNA repair and breast carcinoma susceptibility in women. Cancer 100:1352-1357.
17. Kovacs E, Almendral A (1987) Reduced DNA repair synthesis in healthy women having first degree relatives with breast cancer. Eur J Cancer Clin Oncol 23:1051-1057.
18. Xiong P, et al. (2001) Sensitivity to benzo(a)pyrene diol-epoxide associated with risk of breast cancer in young women and modulation by glutathione S-transferase polymorphisms: A case-control study. Cancer Res 61:8465-8469.
19. Shi Q, et al. (2004) Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients. Carcinogenesis 25:1695-1700.
20. Motykiewicz G, et al. (2002) Removal of benzo(a)pyrene diol epoxide (BPDE)-DNA adducts as a measure of DNA repair capacity in lymphoblastoid cell lines from sisters discordant for breast cancer. Environ Mol Mutagen 40:93-100.
21. Kennedy DO, et al. (2005) DNA repair capacity of lymphoblastoid cell lines from sisters discordant for breast cancer. J Natl Cancer Inst 97:127-132.
22. Hartman AR, Ford JM (2002) BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair. Nat Genet 32:180-184.
23. Takimoto R, et al. (2002) BRCA1 transcriptionally regulates damaged DNA binding protein (DDB2) in the DNA repair response following UV-irradiation. Cancer Biol Ther 1:177-186.
24. Jemal A, et al. (2008) Cancer statistics, 2008. CA Cancer J Clin 58:71-96.
25. Singletary SE, et al. (2002) Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 20:3628-3636.
26. Ethier SP (1996) Human breast cancer cell lines as models of growth regulation and disease progression. J Mammary Gland Biol Neoplasia 1:111-121.
27. Gierach G, Vogel VG (2004) Epidemiology of breast cancer. Advanced Therapy of Breast Disease, eds Singletary SE, Robb GL, Hortobagyi GN (BC Decker, Hamilton, ON, Canada), 2nd Ed, pp 58-74.
28. Betts KS (2007) Secondhand suspicions: Breast cancer and passive smoking. Environ Health Perspect 115:A136-A143.
29. Perou CM, et al. (2000) Molecular portraits of human breast tumours. Nature 406: 747-752.
30. van 't Veer LJ, et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530-536.
31. Sørlie T, et al. (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100:8418-8423.
32. Gaivão I, Piasek A, Brevik A, Shaposhnikov S, Collins AR (2009) Comet assay-based methods for measuring DNA repair in vitro; estimates of inter- and intra-individual variation. Cell Biol Toxicol 25:45-52.
33. Latimer JJ (2000) US patent 6,383,805.
34. Latimer JJ, et al. (2003) Unique tissue-specific level of DNA nucleotide excision repair in primary human mammary epithelial cultures. Exp Cell Res 291:111-121.
35. Latimer JJ, Hultner ML, Cleaver JE, Pedersen RA (1996) Elevated DNA excision repair capacity in the extraembryonic mesoderm of the midgestation mouse embryo. Exp Cell Res 228:19-28.
36. Latimer JJ, et al. (2008) Cell-type-specific level of DNA nucleotide excision repair in primary human mammary and ovarian epithelial cell cultures. Cell Tissue Res 333:461-467.
37. Latimer JJ, et al. (2005) Haploinsufficiency for BRCA1 is associated with normal levels of DNA nucleotide excision repair in breast tissue and blood lymphocytes. BMC Med Genet 6:26.
38. Shuck SC, Short EA, Turchi JJ (2008) Eukaryotic nucleotide excision repair: From understanding mechanisms to influencing biology. Cell Res 18:64-72.
39. Fousteri M, Mullenders LHF (2008) Transcription-coupled nucleotide excision repair in mammalian cells: Molecular mechanisms and biological effects. Cell Res 18:73-84.
40. Jaspers NGJ, et al. (2007) First reported patient with human ERCC1 deficiency has cerebro-oculo-facio-skeletal syndrome with a mild defect in nucleotide excision repair and severe developmental failure. Am J Hum Genet 80:457-466.
41. Dworaczek H, Xiao W (2007) Xeroderma pigmentosum: A glimpse into nucleotide excision repair, genetic instability, and cancer. Crit Rev Oncog 13:159-177.
42. Neumann AS, Sturgis EM, Wei Q (2005) Nucleotide excision repair as a marker for susceptibility to tobacco-related cancers: A review of molecular epidemiological studies. Mol Carcinog 42:65-92.
43. Martin LP, Hamilton TC, Schilder RJ (2008) Platinum resistance: The role of DNA repair pathways. Clin Cancer Res 14:1291-1295.
44. Nordstrand LM, Ringvoll J, Larsen E, Klungland A (2007) Genome instability and DNA damage accumulation in gene-targeted mice. Neuroscience 145:1309-1317.
45. Maddukuri L, Dudziń ska D, Tudek B (2007) Bacterial DNA repair genes and their eukaryotic homologues: 4. The role of nucleotide excision DNA repair (NER) system in mammalian cells. Acta Biochim Pol 54:469-482.
46. Castro MAA, Mombach JC, de Almeida RM, Moreira JC (2007) Impaired expression of NER gene network in sporadic solid tumors. Nucleic Acids Res 35:1859-1867.
47. Hansen MF, et al. (1985) Osteosarcoma and retinoblastoma: A shared chromosomal mechanism revealing recessive predisposition. Proc Natl Acad Sci USA 82:6216-6220.
48. de Vries A, et al. (1997) Induction of DNA adducts and mutations in spleen, liver and lung of XPA-deficient/lacZ transgenic mice after oral treatment with benzo[a]pyrene: Correlation with tumour development. Carcinogenesis 18:2327-2332.
49. Takahashi Y, et al. (2002) Enhanced spontaneous and aflatoxin-induced liver tumorigenesis in xeroderma pigmentosum group A gene-deficient mice. Carcinogenesis 23: 627-633.
50. Ferguson AT, et al. (2000) High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. Proc Natl Acad Sci USA 97:6049-6054.
51. Kleijer WJ, van der Sterre MLT, Garritsen VH, Raams A, Jaspers NGJ (2007) Prenatal diagnosis of xeroderma pigmentosum and trichothiodystrophy in 76 pregnancies at risk. Prenat Diagn 27:1133-1137.
52. Grant SG, Reeger W, Wenger SL (1997-1998) Diagnosis of ataxia telangiectasia with the glycophorin A somatic mutation assay. Genet Test 1:261-267.
53. Evdokimova VN, McLoughlin RK, Wenger SL, Grant SG (2005) Use of the glycophorin A somatic mutation assay for rapid, unambiguous identification of Fanconi anemia homozygotes regardless of GPA genotype. Am J Med Genet A 135:59-65.
54. Kaneko M, Cerutti PA (1980) Excision of N-acetoxy-2-acetylaminofluorene- induced DNA adducts from chromatin fractions of human fibroblasts. Cancer Res 40:4313-4319.
55. Pi-Sunyer FX (2000) Obesity: Criteria and classification. Proc Nutr Soc 59:505-509.
56. Ince TA, et al. (2007) Transformation of different human breast epithelial cell types leads to distinct tumor phenotypes. Cancer Cell 12:160-170.
57. Dairkee SH, et al. (2008) Bisphenol A induces a profile of tumor aggressiveness in high-risk cells from breast cancer patients. Cancer Res 68:2076-2080.
58. Kelly CM, Latimer JJ (2005) Unscheduled DNA synthesis: A functional assay for global genomic nucleotide excision repair. Methods Mol Biol 291:303-320.